Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The New Zealand Medical Journal
|
November 5, 2013
Barrie David Evans
John H L Matthews
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 3, 2006
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group
Nirdosh Kumar Gogna, John H L Matthews, Sandra L Turner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 27, 2010
T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02
John H L Matthews, Bryan H Burmeister, Martin Borg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 30, 2007
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)
David P Dearnaley, Matthew R Sydes, Ruth E Langley, et al.
Oncology Research
|
June 23, 2004
Estimation of radiation-induced interphase cell death in cultures of human tumor material and in cell lines
Elaine S Marshall, Bruce C Baguley, John H L Matthews, et al.
The Lancet. Oncology
|
March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
David P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2020
Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial
David Joseph, James W Denham, Allison Steigler, et al.
The Lancet. Oncology
|
October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
Andrew Kneebone, Carol Fraser-Browne, Gillian M Duchesne, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The New Zealand Medical Journal
|
November 5, 2013
Barrie David Evans
John H L Matthews
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 3, 2006
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group
Nirdosh Kumar Gogna, John H L Matthews, Sandra L Turner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 27, 2010
T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02
John H L Matthews, Bryan H Burmeister, Martin Borg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 30, 2007
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)
David P Dearnaley, Matthew R Sydes, Ruth E Langley, et al.
Oncology Research
|
June 23, 2004
Estimation of radiation-induced interphase cell death in cultures of human tumor material and in cell lines
Elaine S Marshall, Bruce C Baguley, John H L Matthews, et al.
The Lancet. Oncology
|
March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
David P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2020
Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial
David Joseph, James W Denham, Allison Steigler, et al.
The Lancet. Oncology
|
October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
Andrew Kneebone, Carol Fraser-Browne, Gillian M Duchesne, et al.
Page
of 1